The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues
Several treatments for genetic diseases utilizing recombinant adeno-associated viruses (AAVs) have recently gained approval. However, the development of a greater number of therapeutic AAVs is constrained by c...